ReGen Biologics (ReGen Biologics) Revenue : $1.50 Mil (TTM As of Jun. 2009)

ReGen Biologics Revenue Chart

ReGen Biologics Annual Data
	Trend	Dec99	Dec00	Dec01	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08
Revenue		Get a 7-Day Free Trial					0.50	0.57	0.59	0.99	1.37

ReGen Biologics Quarterly Data
	Sep04	Dec04	Mar05	Jun05	Sep05	Dec05	Mar06	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09
Revenue	Get a 7-Day Free Trial															0.24	0.38	0.42	0.30	0.41

Competitive Comparison of ReGen Biologics's Revenue

For the Medical Instruments & Supplies subindustry, ReGen Biologics's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ReGen Biologics's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ReGen Biologics's Revenue distribution charts can be found below:

* The bar in red indicates where ReGen Biologics's Revenue falls into.

ReGen Biologics Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Jun. 2009 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.50 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ReGen Biologics  (OTCPK:RGBOQ) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

ReGen Biologics Revenue Related Terms

Thank you for viewing the detailed overview of ReGen Biologics's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

ReGen Biologics (ReGen Biologics) Business Description